/ Patients / Disease Education
Chronic Lymphocytic Leukemia
Chronic lymphocytic leukemia is the most common form of adult leukemia and accounts for one-third of all leukemias in the United States. In 2009, more than 15,000 new chronic lymphocytic leukemia cases were expected to be diagnosed and nearly 4,500 people were expected to die from the disease.1 It's estimated that nearly 90,000 people live with chronic lymphocytic leukemia.2 There is currently no cure.3
Chronic lymphocytic leukemia is a slow-growing form of cancer that occurs when abnormal or malignant white blood cells (lymphocytes) are found in the blood and bone marrow. These abnormal cells outnumber the normal white blood cells, making it difficult for the body to fight infection.2,4 While the cause is unknown, chronic lymphocytic leukemia occurs in B-cells, a type of white blood cell.3
-
- Age — largely a disease of older adults, the average age of diagnosis is 72 years5
- Gender/ethnicity — for unknown reasons, the disease occurs more frequently in men than women and has a higher incidence in certain ethnic groups1,6
- Symptoms — include fatigue, paleness, weight loss, repeated infections, swollen lymph nodes or spleen, nosebleeds or hemorrhages1,2
- Screening — no screening tests for early detection are available, but a diagnosis can be made from blood tests and a bone marrow biopsy1,2
-
- Chronic lymphocytic leukemia can progress slowly, often with few symptoms; some people may not experience any signs, symptoms or changes in their health for many years; others can progress very quickly2,6
- Approximately 75 percent of people with chronic lymphocytic leukemia will survive at least five years1
-
- Treatment varies based on the type or stage of cancer, overall health of the patient, and the presence or absence of symptoms; common treatment approaches include watch and wait or observation, chemotherapy, targeted medicine (monoclonal antibody) and bone marrow transplantation2,6,7
- Ongoing research continues to develop options to help people achieve a goal of living without the disease worsening for longer periods of time2,3